ANEFX
Price
$63.21
Change
-$1.35 (-2.09%)
Updated
Feb 21 closing price
Net Assets
36.85B
RNPCX
Price
$62.82
Change
-$0.76 (-1.20%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

ANEFX vs RNPCX

Header iconANEFX vs RNPCX Comparison
Open Charts ANEFX vs RNPCXBanner chart's image
American Funds New Economy A
Price$63.21
Change-$1.35 (-2.09%)
VolumeN/A
Net Assets36.85B
American Funds New Perspective R3
Price$62.82
Change-$0.76 (-1.20%)
VolumeN/A
Net Assets147.51B
ANEFX vs RNPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANEFX vs. RNPCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEFX is a Buy and RNPCX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 148B vs. ANEFX (36.8B). RNPCX pays higher dividends than ANEFX: RNPCX (0.58) vs ANEFX (0.21). ANEFX was incepted earlier than RNPCX: ANEFX (41 years) vs RNPCX (23 years). ANEFX is a more actively managed with annual turnover of: 39.00 vs. RNPCX (17.00). ANEFX (250) and RNPCX (250) have matching initial minimum investment requirements. RNPCX annual gain was more profitable for investors over the last year : 9.95 vs. ANEFX (8.74). ANEFX (32.19) and RNPCX (31.90) have equivalent 5 years return.
ANEFXRNPCXANEFX / RNPCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence41 years23 years-
Gain YTD3.4034.57874%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets36.8B148B25%
Annual Yield % from dividends0.210.5836%
Returns for 1 year8.749.9588%
Returns for 3 years22.0313.46164%
Returns for 5 years32.1931.90101%
Returns for 10 years65.2669.5594%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIXI5.300.18
+3.52%
XIAO-I Corporation
NNDM2.25-0.06
-2.60%
Nano Dimension Ltd
EVOK5.07-0.19
-3.53%
Evoke Pharma, Inc.
Z74.91-3.43
-4.38%
Zillow Group
BEAM30.43-2.71
-8.18%
Beam Therapeutics